Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: Comparison with other neutrophil-derived proteins

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 927-934

  Sugi, Kazunori ^a   Saitoh, Osamu ^a   Hirata, Ichiro ^a   Katsu, Ken Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; LEUKOCYTE ELASTASE; LYSOZYME; MYELOPEROXIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME ASSAY; FECES ANALYSIS; HUMAN; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN STABILITY; ULCERATIVE COLITIS;

ADULT; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HEMOGLOBINS; HUMANS; LACTOFERRIN; LEUKOCYTE ELASTASE; MIDDLE AGED; MURAMIDASE; NEUTROPHILS; PANCREATIC ELASTASE; PEROXIDASE; PROTEINS;

EID: 0029886064     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Saitoh O, Matsumoto H, Sugimori K, et al. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and α1-antitrypsin levels in patients with colorectal diseases. Digestion 1995; 56:67-75.
2. Klass HJ, Neale G. Serum and faecal lysozyme in inflammatory bowel disease. Gut 1978;19:233-9.
3. Hemrika MH, Costongs GMPJ, Engels LGJB, et al. Clinical relevance of lysozyme in the faeces. Neth J Med 1989;34:174-81.
4. Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leukocyte. J Clin Microbiol 1992;30:1238-42.
5. Adeyemi EO, Hodgson HJF. Fecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992;27:139-42.
6. Andus T, Gross V, Caesar I, et al. PMN-elastase in assessment of patients with inflammatory bowel disease. Dig Dis Sci 1993;38:1638-44.
7. Roos D. Neutrophils. In: Roitt IM, Delves PJ, eds. Encyclopedia of immunology. London: Academic Press, 1992:1163-6.
8. Borregaard N. The human neutrophil. Function and dysfunction. Eur J Haematol 1988;41:401-13.
9. Pinkus GS, Said JW. Profile of intracytoplasmic lysozyme in normal tissues, myeloproliferative disorders, hairy cell leukemia, and other pathologic processes. Am J Pathol 1977;89:351-66.
10. Cramer EM, Breton-Gorius J. Ultrastructural localization of lysozyme in human neutrophils by immunogold. J Leukocyte Biol 1987;41: 242-7.
11. Querinjean P, Masson PL, Heremans JF. Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur J Biochem 1971;20:420-5.
12. Mason DY, Taylor CR. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol 1978;31:316-27.
13. Reitamo S, Konttinen YT, Segerberg-Konttinen M. Distribution of lactoferrin in human salivary glands. Histochemistry 1980;66:285-91.
14. Iyer S, Lönnerdal B. Lactoferrin, lactoferrin receptors and iron metabolism. Eur J Clin Nutr 1993;47:232-41.
15. Naidu SS, Svensson U, Kishore AR, et al. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 1993;37:240-5.
16. Yamauchi K, Tomita M, Giehl TJ, et al. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61:719-28.
17. Uchida K, Matsuse R, Tomita S, et al. Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994;27:259-64.
18. Travis J, Salvesen GS. Human plasma proteins inhibitors. Annu Rev Biochem 1983;52:655-709.
19. Saitoh O, Sugi K, Matsuse R, et al. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases. Am J Gastroenterol 1995;90:388-93.
20. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984;87:1344-50.
21. Jollès P, Jollès J. What's new in lysozyme research? Mol Cell Biochem 1984;63:165-89.
22. Saito H, Kasajima T, Masuda A, et al. Lysozyme localization in human gastric and duodenal epithelium. An immunocytochemical study. Cell Tissue Res 1988;251:307-13.
23. Stirling JW. Ultrastructual localization of lysozyme in human colon eosinophils using the protein A-gold technique: Effects of processing on probe distribution. J Histochem Cytochem 1989;37:709-14.
24. Brouwer J, Smekens F. Instability of fecal lysozyme. Clin Chim Acta 1991;201:137-8.
25. van Oss CJ, Singer JM. The binding of immune globulins and other proteins by polystyrene latex particles. J Reticuloendothel Soc 1966; 3:29-40.
26. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1:89-92.
27. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976;70:439-44.
28. Nakane PK, Kawaoi A. Peroxidase-labeled antibody, a new method of conjugation. J Histochem Cytochem 1974;22:1084-91.
29. Kjeldsen J. Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol 1993;28:1-9.
30. Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: What does it mean? Gut 1991;32:174-8.
31. Modigliani R. Endoscopic management of inflammatory bowel disease. Am J Gastroenterol 1994;89:S53-S65.
32. Costongs GMPJ, Hemrika MH, Engels LGJB, et al. Faecal lysozyme: Determination, reference intervals and some data in gastrointestinal disease. Clin Chim Acta 1987;125:125-34.
33. Bainton DF. Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms. J Cell Biol 1973;58:249-64.
34. Evans GA, Farrar W. Phorbol esters. In: Roitt IM, Delves PJ, eds. Encyclopedia of immunology. London: Academic Press, 1992: 1223-5.
35. Williams JG, Hughes LE, Hallett MB. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990;31:187-93.